Artelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese mice

Artelo Biosciences’ oral dual cannabinoid agonist showed weight loss comparable to the GLP-1 semaglutide in obese mice.